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The basal ganglia of rhesus and squirrel monkeys were examined using immunohistochemical techniques with antibodies against the 
neurotensin-related hexapeptides LysS-Asn9-Neurotensin(8 - 13) (LANT6) and Neuromedin N. A high percentage of neurons in both 
segments of globus paUidus and many large neurons of the striatum were found to label for LANT6, but not Neuromedin N. Previous 
studies have shown that LANT6 or a LANT6-1ike substance is present in many pallidal neurons in a wide range of vertebrate species. 
The current results indicate that a LANT6-1ike substance that is distinct from Neuromedin N is also present in many pallidal neurons in 
primates. This raises the possibility that this substance may be involved in neurotransmission between the pallidum and its projection 
targets. 
The neurotensin-related hexapeptide Lys8-Asn 9- 
Neurotensin(8-13) (LANT6)  5'6'7 has been found in 
the vast majority of pallidal neurons in the avian ba- 
sal ganglia 28'29. Many of  these neurons have been 
shown to give rise to a LANT6-containing projection 
to tegmental dopaminergic neurons. Biochemical 
and immunohistochemical studies have also revealed 
the presence of  a LANT6-1ike peptide in many palli- 
dal neurons of the basal forebrain in turtles and ham- 
sters 28'29. Although the substance in pallidal neurons 
in turtles and hamsters may differ from avian LANT6  
as sequenced by Carraway and Ferris4, the 
LANT6-1ike peptide found in pallidal neurons in 
these animal groups is not  neuromedin N, a neuro- 
tensin-related hexapeptide isolated originally from 
porcine spinal cord and differing from LANT6 by the 
substitution of  isoleucine for asparagine as the sec- 
ond amino acid 19, or neurotensin itself. Immunohis- 
tochemical studies have shown that a LANT6-1ike 
peptide is also present in pallidal neurons in other 
reptiles (crocodilians), as well as in bony fish (lung- 
fish) and cartilaginous fish (sharks) 28-3°. Since pallidal 
neurons are thought to use y-aminobutyric acid 
(GABA)  as their neurotransmitter 17, the above re- 
suits suggest that LANT6  and G A B A  may co-occur 
in pallidal neurons. Double-label studies specifically 
examining this issue in pigeons have shown that 
G A B A  and LANT6 do co-occur in many pallidal 
neurons of the avian basal telencephalon 26. Thus, the 
studies noted above raise the possibility that pallidal 
neurons in a wide variety of  vertebrate species may 
use G A B A ,  as well as LANT6  or a LANT6-1ike sub- 
stance, to influence neurons in their projection tar- 
gets. Although no data are available on the influence 
of LANT6 on neurons in the target areas of pallidal 
neurons, several lines of  evidence suggest that 
LANT6 may influence these target neurons. First, 
LANT6 is highly concentrated in synaptosomal frac- 
tions of avian brain, suggesting that it may be a neu- 
roactive substance released by synaptic terminals 6. 
Second, LANT6  does appear to bind to neurotensin 
receptors, although with low affinity 9'16, and neuro- 
tensin receptors are rich in at least one target area of 
pallidal neurons, namely the dopaminergic neurons 
of the tegmentum 3'21,21,25. Finally, substances related 
in structure to LANT6 (such as Neuromedin N and 
Correspondence: A. Reiner, Department of Anatomy and Neurobiology, The University of Tennessee Memphis, The Health 
Science Center, Memphis, TN 38163, U.S.A. 
0006-8993/87/$03.50 ~ 1987 Elsevier Science Publishers B.V. (Biomedical Division) 
neurotensin) are known to activate tegmental  dopa- 
minergic neurons 1'13-15'33. In the light of the possible 
role of  L A N T 6  (or LANT6-1ike substances) as a 
neurotransmitter utilized by pallidal neurons and in 
the light of  its phylogenetic ubiquity in pallidal neu- 
rons, the present studies were undertaken to deter- 
mine if a LANT6-1ike peptide is also present in palli- 
dal neurons in primates. 
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One rhesus monkey  and two squirrel monkeys 
were deeply anesthetized with sodium pentobarbital  
and perfused transcardially with 0.1 M phosphate 
buffer (pH 7.2) followed by 4% paraformaldehyde in 
0.1 M phosphate buffer (pH 7.2). The brains were re- 
moved,  postfixed for 2 - 6  h and then stored in a solu- 
tion of 20% sucrose-10% glycerin-0.1% sodium az- 
ide in 0.1 M phosphate buffer (pH 7.2) at 4 °C until 
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Fig. 1. Line drawings illustrating the distribution of LANT6+ neurons in the basal telencephalon of rhesus monkey at a rostral (A) and 
a caudal (B) level of the basal ganglia. Each dot represents one labeled cell body. The section thickness was 40/~m. The low numbers 
of labeled cell bodies in the ventromedial portion of GPi in part reflect the low density of LANT6+ neurons in this region, but also re- 
flect the overall lower density of neurons in this portion of the pallidum. AC, anterior commissure; Cd, caudate; GPe, external seg- 
ment of globus pallidus; GPi, internal segment of globus pallidus; nB, nucleus basalis/diagonal band of Broca region; Pt, putamen; 
TuOI, olfactory tubercle; VP, ventral pallidum. 
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Fig. 2. Photomicrographs of LANT6+ neurons in the basal ganglia of monkeys. A: LANT6+ striatal neurons in rhesus monkey. B: a 
single LANT6+ striatal neuron at a slightly higher power in rhesus monkey, showing some dendritic labeling. C: LANT6+ pallidal 
neurons in the lateral pallidal segment of rhesus monkey. D: LANT6+ neurons in the medial pallidal segment of squirrel monkey. 
Bars: A = 100pm; B = 250/tin. Bar in A applies also to C and D. 
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sectioned. Sections through the basal ganglia were 
sectioned at 30-40/~m on a sliding microtome and 
processed according to the peroxidase-antiperoxi- 
dase (PAP) procedure as described previously 2s'29, 
using antisera against either neurotensin (purchased 
from the ImmunoNuclear Corporation), Neurome- 
din N (NMN) (provided by R.E. Carraway) or 
LANT6 (provided by R.E. Carraway). The specifici- 
ty of these antisera for their target peptides has been 
confirmed in previous studies 6'28'29 and was also eval- 
uated in the present studies. In brief, the anti- 
LANT6 antiserum is specific for the N-terminus of 
LANT6 and does not cross-react with either neuro- 
tensin or NMN. While neither the anti-neurotensin 
antiserum nor the anti-NMN antiserum cross-react 
with LANT6, they do cross-react slightly with one 
another's antigens. 
Using the anti-LANT6 antiserum, abundant 
heavily labeled neurons were found in both segments 
of the globus pallidus (Figs. 1,2). Neuronal labeling 
was not observed in either segment of globus pallidus 
with either the anti-neurotensin antiserum or the 
anti-NMN antiserum. The perikarya of the LANT6+ 
neurons in globus pallidus were either ovoid or poly- 
gonal in shape, with the former ranging from 20 to 30 
ktm in diameter and the latter from 20 to 30/~m in the 
short axis and 30-40/~m in the long axis. Pallidal neu- 
rons in adjacent sections stained with Cresyl violet 
were typically of a similar size and shape as the 
LANT6+ pallidal neurons. In rhesus monkey, the 
number of LANT6+ neurons in globus pallidus per 
unit area in immunohistochemically processed sec- 
tions was compared to the number of neurons in glo- 
bus pallidus per unit area in adjacent Nissl-stained 
sections. The results indicated that a greater percen- 
tage of the neurons in the lateral globus pallidus (ap- 
proximately 75%) were labeled for LANT6 than in 
the medial globus pallidus (approximately 50%). 
LANT6+ neurons were also observed in the stria° 
rum (Figs. 1,2). These neurons were not labeled with 
either the anti-neurotensin antiserum or the anti- 
NMN antiserum. These LANT6÷ striatal neurons 
were also large (approximately 20/~m) and their peri- 
karya were typically round or polygonal in shape. 
These striatal neurons made up only a small percentage 
of the total number of striatal neurons (less than 
1%). In Nissl-stained sections, neurons of this size 
and shape were also observed to be rare and make up 
less than 1% of the total number of striatal neurons 
(the vast majority of which, as reported by others, 
are medium-sized) 7. Since the dendrites of these 
LANT6+ neurons were generally not well-labeled, 
the dendritic morphology of these neurons could not 
be well characterized. In the case of those perikarya 
where some dendritic labeling was observed, 3 or 
more thin dendrites were observed to extend from 
the cell body. The LANT6+ neurons were found 
throughout the striatum and, as shown in Fig. 1, they 
were not uniformly distributed in the striatum. To de- 
termine the relationship of the distribution of these 
neurons to the cholinesterase-poor patches of the 
striatum TM, the distribution of LANT6+ neurons was 
compared to the cholinesterase staining pattern 
(using the procedure of Mesulam and Van Hoesen TM) 
in adjacent sections. The results indicated that, al- 
though LANT6+ neurons are not uniformly distrib- 
uted in the striatum, neither regions of high 
LANT6+ perikaryal density nor regions of low 
LANT6+ perikaryal density consistently correlated 
with either ACHE-poor  or ACHE-rich zones. Thus, 
LANT6+ neurons are present in both patch and ma- 
trix compartments of the striatum. Finally, as in pi- 
geons, turtles and hamsters 2s'29, LANT6+ neurons 
were also observed in the ventral pallidum and in the 
polymorph layer of the olfactory tubercle (Fig. 1). 
Additional LANT6+ neurons were observed in the 
diagonal band of Broca/nucleus basalis portion of the 
telencephalon. As in the case of the striatum and glo- 
bus pallidus, the LANT6+ neurons in these regions 
were large (20-30/~m). 
The present results thus show that in primates, as 
in hamsters and a variety of non-mammalian spe- 
cies 28-3°, a LANT6-1ike substance is present in neu- 
rons of globus pallidus. Although the precise identity 
of the LANT6-1ike substance in paUidal neurons in 
monkeys is unknown, this substance clearly is distinct 
from NMN and neurotensin (which are related in 
structure to LANT6), since pallidal neurons were not 
labeled with antisera against these substances. These 
latter antisera did, however, label neurons and fibers 
in other brain regions, thus suggesting that their fail- 
ure to label pallidal neurons reflects the absence of 
neurotensin and NMN from pallidal neurons. Thus, 
as also recently shown in another mammalian species 
(i.e. hamsters) 29, the present results show that the 
nervous system of monkeys contains neurotensin, 
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NMN and a distinct LANT6-1ike peptide, and that it 
is the LANT6-1ike peptide that is present in pallidal 
neurons. Previous studies in birds have shown that 
LANT6 is present in GABAergic pallidal neurons 26. 
Pallidal neurons in mammals are also thought to use 
GABA as their transmitter. In the light of this and in 
the light of the large number of LANT6+ pallidal 
neurons observed in monkeys, it appears likely that 
GABAergic pallidal neurons in monkeys contain a 
LANT6-1ike peptide. 
The present results show that LANT6+ neurons 
are also present in the striatum in monkeys. These 
neurons are large, presumably aspiny, neurons that 
make up fewer than 1% of the total number of striatal 
neurons. These neurons are present in both patch 
and matrix compartments. LANT6+ striatal neurons 
are also present in the basal ganglia of birds and rep- 
tiles, but have not been observed in hamsters 29. The 
failure to observe LANT6+ striatal neurons in ham- 
sters is of uncertain significance. Possibly these neu- 
rons are absent in hamsters, or possibly the LANT6- 
like substance they putatively contain differs consid- 
erably from avian LANT6 and is only poorly de- 
tected by the present antiserum against LANT6. 
Regardless, the present results clearly show that 
LANT6+ striatal neurons are demonstrable in at 
least some mammalian species. The precise relation- 
ship of these neurons to previously identified types of 
striatal neurons in mammals is uncertain. Since all 
LANT6+ striatal neurons in birds also contain 
GABA 26, it is possible that the LANT6+ striatal 
neurons in monkeys correspond to a class of large 
neurons that also contain GABA,  such as the class of 
large striatonigral projection neurons reported in the 
striatum of some mammals 2. The LANT6+ striatal 
neurons, however, also show morphological resem- 
blances to cholinergic striatal neurons 24, and the pos- 
sibility cannot be excluded that some of the 
LANT6+ striatal neurons contain acetylcholine. It is 
clear, however, that the LANT6+ striatal neurons 
differ in size and morphology from the neurotensin- 
containing striatal neurons recently described in cats 
by Sugimoto and Mizuno 31, which are medium-sized 
spiny neurons. 
The precise functional significance of the presence 
of a LANT6-1ike peptide in pallidal neurons has not 
yet been determined. Existing data, however, raise 
the possibility that at least some pallidal neurons use 
LANT6 as a neurotransmitter in feedback regulation 
of the dopaminergic neurons projecting to the basal 
ganglia. First, in both birds and reptiles, many 
LANT6+ pallidal neurons have been shown to pro- 
ject to the tegmental dopaminergic cell groups 29. 
Similarly, in mammals, the olfactory tubercle, the 
ventral pallidum and the lateral globus pallidus pro- 
ject to the ventral tegmental area and substantia ni- 
gra, which are rich in dopaminergic neurons 11"12' 
20,23,32, and it appears likely that LANT6+ neurons 
are among those projecting to these tegmental sites. 
Secondly, LANT6 has some affinity for neurotensin 
receptors and neurotensin receptors are present on 
tegmental dopaminergic neurons 9A6'22'25. Finally, 
neurotensin and NMN (both of which are structurally 
related to LANT6) are known to activate dopaminer- 
gic neurons, thus suggesting that LANT6 may also be 
able to influence dopaminergic neurons 1'13-15'21'33. 
LANT6+ neurons were also observed in the medi- 
al pallidum segment (which projects to the ventral 
anterior/ventral lateral nuclei and the centromedia- 
num/parafascicular complex of the thalamus) 7's' 
11,12,20,23. Thus, it seems possible that medial pallidal 
neurons also use a LANT6-1ike peptide to influence 
their thalamic target neurons. However, since in rhe- 
sus monkey, as in hamsters, LANT6+ neurons are 
more abundant in the lateral portion of the pallidum 
than in the medial, the LANT6-1ike peptide in palli- 
dal neurons in mammals may play a greater role in 
neurotransmission in the target areas of the lateral 
pallidum (which also include the subthalamic nu- 
cleus) 7,8,12.20, than in target areas of the medial palli- 
dum. Further understanding of the role of LANT6 
would be aided by clarification of the identity and dis- 
tribution of the receptor sites to which LANT6 binds. 
In summary, although much remains to be deter- 
mined about the functional significance of the pres- 
ence of LANT6 in pallidal neurons and of its appar- 
ent co-localization with GABA,  it is clear that a 
LANT6-1ike peptide is present in pallidal neurons in 
vertebrate species as distantly related as sharks and 
primates. These results reinforce previous observa- 
tions on the high degree of evolutionary conserva- 
tism in the neurotransmitter/neuropeptide-specific 
populations of neurons making up the basal gan- 
glia 27. Further, in the light of the striking evolutio- 
nary conservatism in the presence of LANT6 (or re- 
lated substances) in pallidal neurons, it seems likely 
that  L A N T 6  plays a f u n d a m e n t a l  role  in the  func- 
tions of  pal l idal  neurons .  
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